Is pharma rolling in cash or on the brink of a long-term decline? - Healthcare Economist "Although successful drugs often
Is pharma rolling in cash or on the brink of a long-term decline? - Healthcare Economist "Although successful drugs often are expensive, most drugs fail. Thus, while the returns from a blockbuster drug are large, returns from a companies’ entire portfolio may be very modest. Additionally, finding...
Source: healthcare-economist.com
RSS feed